Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin lymphoma

Drugs of Today

Volumn 40, Issue 10, 2004, Pages 865-879

  Wahner Roedler, Dietlind L ^a   Petersen, Ivy A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ESTROGEN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; PROGESTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

AGE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER SCREENING; CANCER STAGING; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CORRELATION ANALYSIS; FEMALE FERTILITY; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HODGKIN DISEASE; HORMONAL REGULATION; HUMAN; MAMMOGRAPHY; OUTCOMES RESEARCH; PRIMARY PREVENTION; PROGNOSIS; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION FIELD; RECURRENT CANCER; REVIEW; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION;

AGE FACTORS; BREAST NEOPLASMS; FEMALE; HODGKIN DISEASE; HUMANS; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY; RETROSPECTIVE STUDIES; RISK; TIME FACTORS;

EID: 8744258884     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2004.40.10.863746     Document Type: Review

References (75)

1. Miller, B.A., Ries, L.A.G., Hankey, B.F. et al. SEER Cancer Statistics Review: 1973-1990, National Cancer Institute. NIH Pub. No. 93-2789, 1993.
2. Ng, A.K., Bernardo, M.P., Weller, E. et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002, 20: 2101-8.
3. Ng, A.K., Bernardo, M.V.P., Weller, E. et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors. Blood 2002, 100: 1989-96.
4. Kelsey, J.L., Berkowitz, G.S. Breast cancer epidemiology. Cancer Res 1988, 48: 5615-23.
5. Gutensohn, N., Cole, P. Childhood social environment and Hodgkin's disease. N Engl J Med 1981, 304: 135-40.
6. Tokunaga, M., Land, C.E., Tokuoka, S., Nishimori, I., Soda, M., Akiba, S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res 1994, 138: 209-23.
7. Vaughan, T.L., Lee, J.A., Strader, C.H. Breast cancer incidence at a nuclear facility: Demonstration of a morbidity surveillance system. Health Phys 1993, 64: 349-54.
8. Pukkala, E., Auvinen, A., Wahlberg, G. Incidence of cancer among Finnish airline cabin attendants, 1967-92. BMJ 1995, 311: 649-52.
9. Boice, J.D., Jr., Mandel, J.S., Morin Doody, M. Breast cancer among radiologic technologists. JAMA 1995, 274: 394-401.
10. Myrden, J.A., Hiltz, J.E. Breast cancer following multiple fluoroscopies during artifical pneumothorax treatment of pulmonary tuberculosis. Can Med Assoc J 1969, 100: 1032-4.
11. Miller, A.B., Howe, G.R., Sherman, G.J. et al. Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis. N Engl J Med 1989, 321: 1285-9.
12. Morin Doody, M., Lonstein, J.E., Stovall, M., Hacker, D.G., Luckyanov, N., Land, C.E. Breast cancer mortality after diagnostic radiography: Findings from the U.S. Scoliosis Cohort Study. Spine 2000, 25: 2052-63.
13. Baral, E., Larsson, L.E., Mattsson, B. Breast cancer following irradiation of the breast. Cancer 1977, 40: 2905-10.
14. Mattsson, A., Ruden, B.I., Hall, R, Wilking, N., Rutqvist, L.E. Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst 1993, 85: 1679-85.
15. Shore, R.E., Hempelmann, L.H., Kowaluk, E. et al. Breast neoplasms in women treated with x-rays for acute postpartum mastitis. J Natl Cancer Inst 1977, 59: 813-22.
16. Shore, R.E., Hildreth, N., Woodard, E., Dvoretsky, P., Hempelmann, L., Pasternack, B. Breast cancer among women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst 1986, 77: 689-96.
17. Modan, B., Chetrit, A., Alfandary, E., Katz, L. Increased risk of breast cancer after low-dose irradiation. Lancet 1989, 1: 629-31.
18. Hildreth, N.G., Shore, R.E., Dvoretsky, P.M. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 1989, 321: 1281-4.
19. Boice, J.D., Jr., Blettner, M., Kleinerman, R.A. et al. Radiation dose and breast cancer risk in patients treated for cancer of the cervix. Int J Cancer 1989, 44: 7-16.
20. Jhaveri, R., Brief, D.K., Schweitzer, V. Breast cancer after radiation exposure in childhood. N J Med 1993, 90: 234-6.
21. Goss, P.E., Sierra, S. Current perspectives on radiation-induced breast cancer. J Clin Oncol 1998, 16: 338-47.
22. Wolden, S.L., Hancock, S.L., Carlson, R.W., Goffinet, D.R., Jeffrey, S.S., Hoppe, R.T. Management of breast cancer after Hodgkin's disease. J Clin Oncol 2000, 18: 765-72.
23. Gervais-Fagnou, D.D., Girouard, C., Laperriere, N., Pintillie, M., Goss, P.E. Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease. Oncology 1999, 57: 224-31.
24. Yahalom, J., Petrek, J.A., Biddinger, P.W. et al. Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 1992, 10: 1674-81.
25. Janjan, N.A., Wilson, J.F., Gillin, M. et al. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer 1988, 61: 252-4.
26. Anderson, N., Lokich, J. Bilateral breast cancer after cured Hodgkin's disease. Cancer 1990, 65: 221-3.
27. Li, F.P., Corkery, J., Canellos, G., Neitlich, H.W. Breast cancer after Hodgkin's disease in two sisters. Cancer 1981, 47: 200-2.
28. Colvett, K.T. Bilateral breast carcinoma after radiation therapy for Hodgkin's disease. South Med J 1995, 88: 239-42.
29. Geffen, D.B., Krause, I., Faermann, S., Krutman, Y., Vinograd, L., Cohen, Y. Bilateral synchronous breast carcinoma with axillary node involvement fifteen years after radiotherapy for Hodgkin's disease (letter). Acta Oncol 1992, 31: 477-8.
30. Wahner-Roedler, D.L., Nelson, D.F., Croghan, I.T. et al. Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience. Mayo Clin Proc 2003, 78: 708-15.
31. van Leeuwen, F.E., Klokman, W.J., Veer, M.B. et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000, 18: 487-97.
32. Swerdlow, A.J., Barber, J.A., Hudson, G.V. et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment. J Clin Oncol 2000, 18: 498-509.
33. Hudson, M.M., Poquette, C.A., Lee, J. et al. Increased mortality after successful treatment for Hodgkin's disease. J Clin Oncol 1998, 16: 3592-600.
34. Wolden, S.L., Lamborn, K. R., Cleary, S.F., Tate, D.J., Donaldson, S.S. Second cancers following pediatric Hodgkin's disease. J Clin Oncol 1998, 16: 536-44.
35. Hoppe, R.T. Hodgkin's disease: Complications of therapy and excess mortality. Ann Oncol 1997, 8 (Suppl. 1): 115-8.
36. Chung, C.T., Bogart, J.A., Adams, J.F. et al. Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1997, 37: 405-9.
37. Tinger, A., Wasserman, T.H., Klein, E.E. et al. The incidence of breast cancer following mantle field radiation therapy as a function of dose and technique. Int J Radiat Oncol Biol Phys 1997, 37: 865-70, 38.
38. Bhatia, S., Robison, L.L., Oberlin, O. et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996, 334: 745-51.
39. Mauch, P.M., Kalish, L.A., Marcus, K.C. et al. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome. Blood 1996, 87: 3625-32.
40. Salloum, E., Doria, R., Schubert, W. et al. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation. J Clin Oncol 1996, 14: 2435-43.
41. Hancock, S.L., Tucker, M.A., Hoppe, R.T. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 1993, 85: 25-31.
42. Prior, P., Pope, D.J. Hodgkin's disease: Subsequent primary cancers in relation to treatment. Br J Cancer 1988, 58: 512-7.
43. Curtis, R.E., Boice, J.D., Jr. Second cancers after radiotherapy for Hodgkin's disease (letter). N Engl J Med 1988, 319: 244-6.
44. Tucker, M.A., Coleman, C.N., Cox, R.S., Varghese, A., Rosenberg, S.A. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988, 318: 76-81.
45. Kaldor, J.M., Day, N.E., Band, P. et al. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries. Int J Cancer 1987, 39: 571-85.
46. Carey, R.W., Linggood, R.M., Wood, W., Blitzer, P.H. Breast cancer developing in four women cured of Hodgkin's disease. Cancer 1984, 54: 2234-6.
47. Metayer, C., Lynch, C.F., Clarke, E.A. et al. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 2000, 18: 2435-43.
48. Travis, L.B., Curtis, R.E., Boice, J.D., Jr. Late effects of treatment for childhood Hodgkin's disease (letter). N Engl J Med 1996, 335: 352-3.
49. Boice, J.D., Jr. Radiation and breast carcinogenesis. Med Pediatr Oncol 2001, 36: 508-13.
50. Yahalom, J. Breast cancer after Hodgkin disease: Hope for a safer cure. JAMA 2003, 290: 529-31.
51. Dores, G.M., Metayer, C., Curtis, R.E. et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years. J Clin Oncol 2002, 20: 3484-94.
52. Preston, D.L., Mattsson, A., Holmberg, E., Shore, R., Hildreth, N.G., Boice, J.D., Jr. Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiat Res 2002, 158: 220-35.
53. Christie, D.R., Wills, R., Drew, J.F., Barton, M.B. The doses received by the breast during mantle radiotherapy. Int J Radiat Oncol Biol Phys 1998, 41: 223-6.
54. Zellmer, D.L., Wilson, J.F., Janjan, N.A. Dosimetry of the breast for determining carcinogenic risk in mantle irradiation. Int J Radiat Oncol Biol Phys 1991, 21: 1343-51.
55. Travis, L.B., Hill, D.A., Dores, G.M. et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003, 290: 465-75.
56. Yahalom, J. Changing role and decreasing size: Current trends in radiotherapy for Hodgkin's disease. Curr Oncol Rep 2002, 4: 415-23.
57. Nachman, J.B., Sposto, R., Herzog, P. et al., for the Children's Cancer Group. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002, 20: 3765-71.
58. Aleman, B.M.P., Raemaekers, J.M.M., Tirelli, U. et al, for the European Organization for Research and Treatment of Cancer Lymphoma Group. Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med 2003, 348: 2396-406.
59. Dietrich, P.Y., Henry-Amar, M., Cosset, J.M., Bodis, S., Bosq, J., Hayat, M. Second primary cancers in patients continuously disease-free from Hodgkin's disease: A protective role for the spleen? Blood 1994, 84: 1209-15.
60. Munker, R., Grutzner, S., Hiller, E. et al. Second malignancies after Hodgkin's disease: The Munich experience. Ann Hematol 1999, 78: 544-54.
61. Linet, M.S., Nyren, O., Gridley, G. et al. Risk of cancer following splenectomy. Int J Cancer 1996, 66: 611-16.
62. Cannellos, G.P., Anderson, J.R., Propert, K.J. et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 1992, 327: 1478-84.
63. Brusamolino, E., Lunghi, F., Orlandi, E. et al. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: Analysis of efficacy and long-term toxicity. Haematologica 2000, 85: 1032-9.
64. Ray, G.R., Trueblood, H.W., Enright, L.P., Kaplan, H.S., Nelsen, T.S. Oophoropexy: A means of preserving ovarian function following pelvic megavoltage radiotherapy for Hodgkin's disease. Radiology 1970, 96: 175-80.
65. Deniz, K., O'Mahony, S., Ross, G., Purushotham, A. Breast cancer in women after treatment for Hodgkin's disease. Lancet Oncol 2003, 4: 207-14.
66. Diehl, V., Franklin, J., Pfreundschuh, M. et al., for the German Hodgkin's Lymphoma Study Group. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 2003, 348: 2386-95.
67. SEER Cancer Statistics Review, 1973-1998. Available at: http://seer.cancer.gov/csd1973_1998. Accessed January 5, 2004.
68. de la Rochefordiere, A., Asselain, B., Scholl, S. et al. Simultaneous bilateral breast carcinomas: A retrospective review of 149 cases. Int J Radiat Oncol Biol Phys 1994, 30: 35-41.
69. Roubidoux, M.A., Helvie, M.A., Lai, N.E., Paramagul, C. Bilateral breast cancer: Early detection with mammography. Radiology 1995, 196: 427-31.
70. Cutuli, B., Dhermain, F., Borel, C. et al. Breast cancer in patients treated for Hodgkin's disease: Clinical and pathological analysis of 76 cases in 63 patients. Eur J Cancer 1997, 33: 2315-20.
71. Karasek, K., Deutsch, M. Lumpectomy and breast irradiation for breast cancer after radiotherapy for lymphoma. Am J Clin Oncol 1996, 19: 451-4.
72. Deutsch, M., Gerszten, K., Bloomer, W.D., Avisar, E. Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma. Am J Clin Oncol 2001, 24: 33-4.
73. Aref, I., Cross, P. Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease. Br J Radiol 2000, 73: 905-6.
74. Overgaard, M., Hansen, P.S., Overgaard, J. et al., for the Danish Breast Cancer Cooperative Group 82b Trial. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997, 337: 949-55.
75. Fisher, B., Costantino, J.P., Wickerham, D.L. et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998, 90: 1371-88.